Jeg er utdannet molekylærbiolog og jobber innen immunogenetikk med fokus på endokrin autoimmun sykdom. Siden disputasen min i 2012 ved Universitetet i Bergen fortsatte jeg som post-Doc i samme gruppe og hadde ett års forskningsopphold hos Professor Hamish Scott ved University of Adelaide hvor jeg jobbet med genetikk. Jeg ble så tildelt et mobilitetsstipend fra Norges Forskningsråd og jobbet to år i gruppen til Professor Georg Holländer ved University of Oxford hvor jeg arbeidet med karakterisering av utvikling av T-celler i tymus. Siden 2019 har jeg vært ansatt som seniorforsker ved KG Jebsen-senteret for autoimmune sykdommer, og jeg ble nylig tildelt det prestisjetunge Excellence Emerging Investigator-stipendet fra Novo Nordic-stiftelsen. Mitt langsiktige mål er å karakterisere genetiske og molekylære mekanismer i det adaptive immunsystemet som er avgjørende for utviklingen av tolerante T-celler og B-celler. Videre vil jeg kombinerer denne kunnskapen i multivariante sykdomsmodeller for bedre å forutsi autoimmunt vevsdestruksjon. I tillegg ønsker jeg å utvide mitt internasjonale nettverk med mulighet for langsiktige samarbeid.

2024: 

Invited speaker at the 21st Biennial Meeting of the European Society for Immunodeficiencies (ESID), Marseille, France, 16.-19. October, 2024

 

2022: 

Invited speaker at European Congress of Endocrinology (ECE) 2022, 21–24 May 2022 in Milan Italy,

Invited speaer at the 20th Biennial Meeting of the European Society for Immunodeficiencies (ESID), Gothenburg, Sweden, 12-15 October, 2022.

2016:    

Invited speaker, 12^th Annual Symposium on Primary Immunodeficiency Diseases, California, USA

Selected speaker at the 43^rd Scandinavian Society for Immunology meeting, Turku, Finland.

       

2015

Selected speaker at The Thymus Meeting 2015, Venice, Italy

Invited speaker at the Norwegian Immunological Society annual meeting

Vitenskapelig artikkel

• Thea Sjøgren; Jan-Inge Bjune; Eystein Sverre Husebye et al. (2024). Regulatory T cells in autoimmune primary adrenal insufficiency. (ekstern lenke)
• Bergithe Eikeland Oftedal; Amund Holte Berger; Øyvind Bruserud et al. (2023). A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Agnieszka Pazderska; Bergithe Eikeland Oftedal; Catherine M. Napier et al. (2016). A variant in the BACH2 gene is associated with susceptibility to autoimmune addison's disease in humans. (ekstern lenke)
• Lucia Gagliardi; Andreas W. Schreiber; Christopher N. Hahn et al. (2014). ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. (ekstern lenke)
• Bergithe Eikeland Oftedal; Nicolas Delaleu; David William Peter Dolan et al. (2023). Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Anette Susanne Bøe Wolff; Jaanika Kärner; Jone Furulund Owe et al. (2014). Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. (ekstern lenke)
• Thea Sjøgren; Eirik Bratland; Ellen Christine Røyrvik et al. (2022). Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies. (ekstern lenke)
• Øyvind Bruserud; Huma Siddiqui; Ileana Mihaela Cuida Marthinussen et al. (2018). Oral microbiota in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Øyvind Bruserud; Eirik Bratland; Alexander Hellesen et al. (2017). Altered immune activation and IL-23 signaling in response to Candida albicans in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lars Ertesvåg Breivik; Karl Ove Hufthammer et al. (2021). The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease. (ekstern lenke)
• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2014). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Amund Holte Berger; Eirik Bratland; Thea Sjøgren et al. (2021). Transcriptional changes in regulatory T cells from patients with autoimmune polyendocrine syndrome type 1 suggest functional impairment of lipid metabolism and gut homing. (ekstern lenke)
• Yael Goldfarb; Tal Givony; Noam Kadouri et al. (2021). Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation. (ekstern lenke)
• Agnethe Berglund; Line Cleemann; Bergithe Eikeland Oftedal et al. (2018). 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Dylan Mordaunt; Bergithe Eikeland Oftedal; Alisha McLauchlan et al. (2015). 8q13.1-q13.2 deletion associated with inferior cerebellar vermian hypoplasia and digital anomalies: A new syndrome?. (ekstern lenke)
• Sigrid Aslaksen; Anette Susanne Bøe Wolff; Magnus Dehli Vigeland et al. (2019). Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen et al. (2017). Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Caleigh Mandel-Brehm; Sara E. Vazquez; Christopher Liverman et al. (2023). Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy. (ekstern lenke)
• Daniel Eriksson; Ellen Christine Røyrvik; Maribel Aranda-Guillen et al. (2021). GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. (ekstern lenke)
• Anette Susanne Bøe Wolff; Adrien Katalin Sarkadi; László Maródi et al. (2013). Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. (ekstern lenke)
• Bergithe Eikeland Oftedal; Sigve Ladstein; Wenche Telle et al. (2005). Ligand-dependent protein interactions of the estrogen receptors using the yeast two-hybrid system. (ekstern lenke)
• Jan Dobeš; Osher Ben-Nun; Amit Binyamin et al. (2022). Extrathymic expression of Aire controls the induction of effective T<inf>H</inf>17 cell-mediated immune response to Candida albicans. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (ekstern lenke)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Eirik Bratland et al. (2008). Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Dorsa Iraji; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff (2023). Th17 Cells: Orchestrators of Mucosal Inflammation and Potential Therapeutic Targets. (ekstern lenke)
• Sigrid Aslaksen; Paal Methlie; Magnus Dehli Vigeland et al. (2019). Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Brita Ardesjo Lundgren; David Hamm et al. (2017). T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ. (ekstern lenke)
• Bergithe Eikeland Oftedal; Kristian Assing; Safa Baris et al. (2023). Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. (ekstern lenke)
• Isil Kucuka; Dorsa Iraji; Sarah Braun et al. (2025). Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. (ekstern lenke)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Kai Kisand et al. (2010). Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Muhammad Rahman; André Sulen; Lars Ertesvåg Breivik et al. (2025). Anti-perilipin-1 autoantibodies in autoimmune Addison’s disease and related endocrine disorders. (ekstern lenke)
• Bergithe Eikeland Oftedal; Stefano Maio; Adam Handel E et al. (2021). The chaperonin CCT8 controls proteostasis essential for T cell maturation, selection, and function. (ekstern lenke)
• shahinul islam; Bergithe Eikeland Oftedal; Miriam Gjerdevik et al. (2025). Immune cell subsets in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Bergithe Eikeland Oftedal; Olle Kämpe; Anthony Meager et al. (2011). Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. (ekstern lenke)
• Zhiqiang Hu; Hamish S. Scott; Guangrong Qin et al. (2015). Revealing missing human protein isoforms based on Ab initio prediction, RNA-seq and proteomics. (ekstern lenke)
• Liv Hapnes; Nick Willcox; Bergithe Eikeland Oftedal et al. (2012). Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. (ekstern lenke)

Masteroppgave

• Bergithe Eikeland Oftedal; Rune Male; Anders Goksøyr (2005). Exploring protein-protein interactions between ligand activated transcription factors using the yeast two-hybrid system. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff (2020). New ERA of therapy for endocrine autoimmune disorders. (ekstern lenke)
• Anette Susanne Bøe Wolff; Sarah Braun; Eystein Sverre Husebye et al. (2021). B cells and autoantibodies in aire deficiency. (ekstern lenke)
• Øyvind Bruserud; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2016). AIRE-mutations and autoimmune disease. (ekstern lenke)
• Andre Sulen; Shahinul Islam; Anette Susanne Bøe Wolff et al. (2020). The prospects of single-cell analysis in autoimmunity. (ekstern lenke)
• Bergithe Eikeland Oftedal; Thea Sjøgren; Anette Susanne Bøe Wolff (2024). Interferon autoantibodies as signals of a sick thymus. (ekstern lenke)
• Anette Susanne Bøe Wolff; Isil Kucuka; Bergithe Eikeland Oftedal (2023). Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives. (ekstern lenke)

Doktorgradsavhandling

• Øyvind Bruserud; Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal et al. (2019). Exploring and redefining Autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Bergithe Eikeland Oftedal (2012). Autoimmune polyendocrine syndrome type I. Novel diagnostic assays and immune regulation. (ekstern lenke)

Konferanseabstrakt

• Anette Susanne Bøe Wolff; A. Ostre; Bergithe Eikeland Oftedal et al. (2012). Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Bergithe Eikeland Oftedal; Martina Moter Erichsen; Alexander Hellesen et al. (2013). Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. (ekstern lenke)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Olle Kämpe et al. (2010). Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). (ekstern lenke)

Vitenskapelig bokkapittel

• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff (2019). Aire Mutations and Autoimmune Diseases. (ekstern lenke)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Eystein Sverre Husebye (2019). The Natural History of APS1. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Utvalgte publikasjoner:

2025

44. Aire-dependent interferon signalling shapes thymocyte maturation and central tolerance in mice.

Jebrzycka A, Breivik L, Dolan D, Goldfarb Y, Abramson J, Wolff ASB, Husebye ES, Joshi A, Oftedal BE.

Commun Biol. 2025 Dec 9. doi: 10.1038/s42003-025-09317-9. PMID: 41366551

 

43. A novel heterozygous pathogenic AIRE variant causing autoimmunity but not infectious susceptibility

Vemula M, Oftedal BE, Iraji D, Migaud M, Richmond C, Lazarus S, Casanova JL, Sullivan A, Puel A, Tangye SG, and Pinzon-Charry A

Rockefeller University Press https://doi.org/10.70962/jhi.20250151, J. Hum. Immun. 2025 Vol. 1 No. 4 e20250151

 

42. Perspectives on Artificial Intelligence in Medical Publishing: A Survey of Medical Journal Editors.

Biondi-Zoccai G, Lauretti A, Agewall S, Andres E, Audisio RA, Bhatt DL, Citerio G, Drezner JA, Eggermont A, Erol C, Ersche KD, Ferriero G, Heusch G, Indolfi C, Insel PA, Lavie CJ, La Vecchia C, Maffulli N, Montecucco F, Moliterno DJ, Nattel S, O'Kane P, Oliaro E, Pelliccia A, Picard M, Pozzilli P, Quaglia F, Riha RL, Sarkar R, Scicchitano P, Teboul JL, Stahel HT, Wold LE, Booz GW; Artificial Intelligence in Medical Publishing (AIMPub) Working Group.

J Cardiovasc Pharmacol. 2025 Oct 1;86(4):374-383. doi: 10.1097/FJC.0000000000001738.PMID: 40693971 

 

41. Immune cell subsets in autoimmune polyendocrine syndrome type I

Islam S, Oftedal BE, Gjerdevik M, Breivik L, Røyrvik EC, Lima K, Jørgensen AP, Nwakwuo I, Skavland J, Husebye ES, Wolff ASB. Sci Rep. 2025 Aug 4;15(1):28398. doi: 10.1038/s41598-025-12634-y.

 

40. High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys.

Berger AH, Oftedal BE, Wolff ASB, Husebye ES, Knappskog PM, Bratland E, Johansson S.

Front Immunol. 2025 Apr 22;16:1572789. doi: 10.3389/fimmu.2025.1572789. 

 

39. Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1.

Kucuka I, Iraji D, Braun S, Breivik L, Wolff ASB, Husebye ES, Oftedal BE.

Scand J Immunol. 2025 Apr;101(4):e70021. doi: 10.1111/sji.70021.

 

38.Anti-perilipin-1 autoantibodies in autoimmune Addison's disease and related endocrine disorders

Rahman MO, Sulen A, Breivik L, Appel S, Anderson MS, Oftedal BE, Wolff ASB, Husebye ES. 

Autoimmunity. 2025 Dec;58(1):2461703. doi: 10.1080/08916934.2025.2461703. 

 

2024:

37. Single cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1 

Sjøgren T, Islam S, Filippov I, Jebrzycka A, Sulen A, Breivik LE, Hellesen A, Jørgensen AP, Lima K, Tserel L, Kisand K, Peterson P, Ranki A, Husebye ES, Oftedal BE, Wolff ASB.

iScience. 2024 Mar 27;27(4):109610. doi: 10.1016/j.isci.2024.109610. eCollection 2024 Apr 19.

 

 

2023:

36. A partial form of AIRE deficiency underlies a mild form of Autoimmune Polyendocrine Syndrome Type 1.

Oftedal BE, Berger AH, Bruserud Ø, Goldfarb Y, Sulen A, Breivik L, Hellesen A, Ben-Dor S, Haffner-Krausz R , Knappskog PM, Johansson S, Wolff ASB, Bratland E, Abramson J, Husebye ES.

J Clin Invest. 2023 Nov 1;133(21):e169704. doi: 10.1172/JCI169704.

 

35. Regulatory T cells in autoimmune primary adrenal insufficiency.

Sjøgren T, Bjune JI, Husebye ES, Oftedal BE, Wolff ASB.

Clin Exp Immunol. 2023 Aug 14: uxad087. doi: 10.1093/cei/uxad087. Online ahead of print.

 

34. Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies.

Wolff ASB, Hansen L, Grytaas MA, Oftedal BE, Breivik L, Zhou F, Hufthammer KO, Sjøgren T, Olofsson JS, Trieu MC, Meager A, Jørgensen AP, Lima K, Greve-Isdahl Mohn K, Langeland N, Cox RJ, Husebye ES.

iScience. 2023 Jul 21;26(7):107084. doi: 10.1016/j.isci.2023.107084. Epub 2023 Jun 9.

 

33. Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes.

Oftedal BE, Assing K, Baris S, Safgren SL, Johansen IS, Jakobsen MA, Babovic-Vuksanovic D, Agre K, Klee EW, Majcic E, Ferré EMN, Schmitt MM, DiMaggio T, Rosen LB, Rahman MO, Chrysis D, Giannakopoulos A, Garcia MT, González-Granado LI, Stanley K, Galant-Swafford J, Suwannarat P, Meyts I, Lionakis MS, Husebye ES.

iScience. 2023 May 5;26(6):106818. doi: 10.1016/j.isci.2023.106818. eCollection 2023 Jun 16.

 

32. Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1.

Oftedal BE, Delaleu N, Dolan D, Meager A, Husebye ES, Wolff ASB.

FEBS Lett. 2023 Apr 13. doi: 10.1002/1873-3468.14625. Online ahead of print. PMID: 37052889

 

31. Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.

Mandel-Brehm C, Vazquez SE, Liverman C, Cheng M, Quandt Z, Kung AF, Parent A, Miao B, Disse E, Cugnet-Anceau C, Dalle S, Orlova E, Frolova E, Alba D, Michels A, Oftedal BE, Lionakis MS, Husebye ES, Agarwal AK, Li X, Zhu C, Li Q, Oral E, Brown R, Anderson MS, Garg A, DeRisi JL.

Diabetes. 2023 Jan 1;72(1):59-70. doi: 10.2337/db21-1172.PMID: 35709010

 

 

2022:

30. Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.

Sjøgren T, Bratland E, Røyrvik EC, Grytaas MA, Benneche A, Knappskog PM, Kämpe O, Oftedal BE, Husebye ES, Wolff ASB.

J Autoimmun. 2022 Dec;133:102917. doi: 10.1016/j.jaut.2022.102917. Epub 2022 Sep 30. PMID: 36191466

 

29. Extrathymic expression of Aire modulates the induction of effective TH17 cell-mediated immune response to Candida albicans.

J Dobeš, O Ben-Nun, A Binyamin, L Stoler-Barak, BE Oftedal, Y Goldfarb, N Kadouri, Y Gruper, T Givony, I Zalayat, K Kováčová, H Böhmová, E Valter, Z Shulman, D Filipp, ES Husebye,  J Abramson

Nat Immunol. 2022 Jul;23(7):1098-1108. doi: 10.1038/s41590-022-01247-6. Epub 2022 Jun 27.

PMID: 35761088

 

2021:

28. Transcriptional Changes in Regulatory T Cells from Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing.

Berger AH, Bratland E, Sjøgren T, Heimli M, Tyssedal T, Bruserud Ø, Johansson S, Husebye ES, Oftedal BE, Wolff ASB.

Front Immunol. 2021 Aug 30;12:722860. doi: 10.3389/fimmu.2021.722860. eCollection 2021.

 

27. Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation

Y. Goldfarb, T. Givony, N. Kadouri, J. Dobeš, C. Peligero-Cruz, I. Zalayat, G. Damari, B. Dassa, S. Ben-Dor, Y. Gruper, BE. Oftedal, E. Bratland, MM. Erichsen, A. Berger, A. Avin, S. Nevo, U. Haljasorg, Y. Kuperman, A. Ulman, R. Haffner-Krausz, Z. Porat, U. Atasoy, D. Leshkowitz, ES. Husebye, J. Abramson

J Exp Med. 2021 Nov 1;218(11):e20201076. doi: 10.1084/jem.20201076. Epub 2021 Sep 3.

 

26. The chaperonin CCT8 controls proteostasis essential for T cell maturation, selection, and function

BE Oftedal, S Maio, A Händel, MPJ White, D Howie, S Davis, N Prevot, IA Rota, ME Deadman, BM Kessler, R Fischer, NS Trede, E Sezgin, RM Maizels, GA Holländer

Nature Communications Biology, Commun. Biol 4, 681 (2021). https://doi.org/10.1038/s42003-021-02203-0

 

25. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease

ASB Wolff, L Breivik, KO Hufthammer, MA Grytaas, E Bratland, ES Husebye, and BE Oftedal

The European Journal of Endocrinology, DOI: https://doi.org/10.1530/EJE-20-1268, Volume/Issue: Volume 184: Issue 4, Page Range: 607–615

 

24. GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.

D Eriksson, EC Røyrvik, M Aranda-Guillén, AH Berger, N Landegren, HA Alvarez, Å Hallgren, M Grytaas, S Ström, E Bratland, I Botusan, BE Oftedal ,…, S Johansson, O Kämpe, ES Husebye.

Nat Commun. 2021 Feb 11;12(1):959. doi: 10.1038/s41467-021-21015-8.

 

2019

23. Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease.

Aslaksen S, Methlie P, Vigeland MD, Jøssang DE, Wolff AB, Sheng Y, Oftedal BE, Skinningsrud B, Undlien DE, Selmer KK, Husebye ES, Bratland E.

Front Endocrinol (Lausanne). 2019 Sep 27;10:648. doi: 10.3389/fendo.2019.00648.

 

22. Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease.

Aslaksen S, Wolff AB, Vigeland MD, Breivik L, Sheng Y, Oftedal BE, Artaza H, Skinningsrud B, Undlien DE, Selmer KK, Husebye ES, Bratland E.

J Transl Autoimmun. 2019 May 28;1:100005. doi: 10.1016/j.jtauto.2019.100005.

 

2018

21. 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.

Berglund A, Cleemann L, Oftedal BE, Holm K, Husebye ES, Gravholt CH.

Clin Exp Immunol. 2018 Oct 29. doi: 10.1111/cei.13231. PMID: 30372540

 

20.Oral microbiota in autoimmune polyendocrine syndrome type 1.

Bruserud Ø, Siddiqui H, Marthinussen MC, Chen T, Jonsson R, Oftedal BE, Olsen I, Husebye ES, Wolff AB.

J Oral Microbiol. 2018 Feb 26;10(1):1442986. doi: 10.1080/20002297.2018.1442986. PMID: 29503707

 

2017

19. Altered Immune Activation and IL-23 Signaling in Response to Candida albicans in Autoimmune

Polyendocrine Syndrome Type 1.

Bruserud Ø, Bratland E, Hellesen A, Delaleu N, Reikvam H, Oftedal BE, Wolff ASB.

Front Immunol. 2017 Sep 1;8:1074. doi: 10.3389/fimmu.2017.01074. eCollection 2017.

PMID: 28919897

 

18. Salivary gland dysfunction in patients with autoimmune polyendocrine syndrome type I

BE Oftedal, M Cuida, MM Erichsen, M Tveiterås, A Østre, D Hammenfors, M Johnsson, K Kisand, R Klein, R Jonsson, ASB Wolff.

Autoimmunity. 2017 Jun;50(4):211-222. doi: 10.1080/08916934.2017.1344972. Epub 2017 Jul 7.

PMID: 28686485

 

17. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type-1.

EM Orlova, LS Sozaeva, MA Kareva, BE Oftedal, ASB Wolff, L Breivik, EY Zakharova, O Kämpe, PM Knappskog, VA Peterkova, ES Husebye. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3546-3556. doi: 10.1210/jc.2017-00139. PMID: 28911151

 

16. T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ

Oftedal, B.E., Lundgren, B.A., Hamm, D., Finstermeier, K., Gan, P.Y., Holdsworth, S.R., Hahn, C.N., Schreiber, A.W., and Scott, H.S.

J Autoimmun. 2017 Mar 15. pii: S0896-8411(16)30344-4. doi: 10.1016/j.jaut.2017.03.002. [Epub ahead of print]. PMID: 28318808

 

2016

15. A Variant in the BACH2 Gene Is Associated With Susceptibility to Autoimmune Addison's Disease in Humans

Pazderska A, Oftedal BE, Napier CM, Ainsworth HF, Husebye ES, Cordell HJ, Pearce SH, Mitchell AL.

J Clin Endocrinol Metab. 2016 Nov;101(11):3865-3869. Epub 2016 Sep 28. PMID: 27680876

 

14. A longitudinal follow-up of Autoimmune polyendocrine syndrome type 1.

Bruserud Ø, Oftedal BE, Landegren N, Erichsen M, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES.

J Clin Endocrinol Metab. 2016 Jun 2:jc20161821. [Epub ahead of print] PMID: 27253668

 

13. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases

BE Oftedal, A Hellesen, MM Erichsen, E Bratland, A Vardi, J Perheentupa, EH Kemp, T Fiskerstrand, MK Viken, AP Weetman, SJ Fleishman, S Banka, WG Newman, WAC Sewell, LS Sozaeva, T Zayats, K Haugarvoll, EM Orlova, J Haavik, S Johansson, PM Knappskog, K Løvås, ASB Wolff, J Abramson, Eystein S. Husebye

Immunity. 2015 Jun 16;42(6):1185-96. doi: 10.1016/j.immuni.2015.04.021. PMID: 26084028

Impact factor: 24.1

 

2015

12. Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics

Hu, Z.-Q., Scott, H.S., Qin, G.-G., Zheng, G.-Y., Chu, X., Xie, L., Adelson, D.L., Oftedal, B.E.,

Venugopal, P., Babic, M., Hahn, C.N., Bing Zhang, B., Wang, X.-J., Nan Li, N., and Wei, C.-C.

SCIENTIFIC REPORTS 2015 Volume: 5, Article Number: 10940

 

11. 8q13.1-q13.2 Deletion Associated With Inferior Cerebellar Vermian Hypoplasia and Digital Anomalies: A New Syndrome?

Mordaunt D, Oftedal BE, Scott HS, Coates D, Barnett C

Pediatr Neurol. 2015 Feb;52(2):230-4.e1. doi: 10.1016/j.pediatrneurol.2014.09.002. PMID: 25693585

 

2014

10. Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen

Transcripts in Their Tumors.

Wolff ASB, Kärner J,Owe JF, Oftedal BE, Gilhus NE. Erichsen MM, Kämpe E,‖ Meager A, Peterson

P, Kisand K, Willcox N, Husebye ES

J Immunol. 2014 Oct 15;193(8):3880-90. doi: 10.4049/jimmunol.1401068. PMID: 25230752

 

9. ARMC5 MUTATIONS ARE COMMON IN FAMILIAL BILATERAL MACRONODULAR ADRENAL

HYPERPLASIA.

Gagliardi L, Schreiber AW, Hahn CN, Feng J, Cranston T, Boon H, Hotu C, Oftedal BE, Cutfield R,

Adelson DL, Braund WJ, Gordon RD, Rees DA, Grossman AB, Torpy DJ, Scott HS.

J Clin Endocrinol Metab. 2014 Jun 6:jc20141265. PMID:24905064

Citations: 36 (webofknowledge.com)

 

8. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.

Breivik L, Oftedal BE, Bøe Wolff AS, Bratland E, Orlova EM, Husebye ES.

Clin Immunol. 2014 Jul;153(1):220-7. doi: 10.1016/j.clim.2014.04.013. Epub 2014 May 2.

 

2013

7. Anti-Cytokine Autoantibodies Preceding Onset of Autoimmune Polyendocrine Syndrome Type I Features in Early Childhood.

Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE, Kisand K, Oláh E, Meloni A, Myhre

AG, Husebye ES, Motaghedi R, Perheentupa J, Peterson P, Willcox N, Meager A.

J Clin Immunol. 2013 Oct 26. [Epub ahead of print

 

2011

6. Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups.

Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS.

J Clin Immunol. 2011 Nov 30. [Epub ahead of print] PMID: 22127461

 

5. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins.

Oftedal BE, Kämpe O, Meager A, Ahlgren KM, Lobell A, Husebye ES, Wolff AS.

Scand J Immunol. 2011 Apr 28. [Epub ahead of print] PMID:21535082

 

2010

4. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in

autoimmune polyendocrine syndrome type I.

Wolff AS, Oftedal BE, Kisand K, Ersvaer E, Lima K, Husebye ES.

Scand J Immunol. 2010 Jun;71(6):459-67. PMID: 20500699

Citations: 24 (webofknowledge.com)

 

2008

3. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune

polyendocrine syndrome type I.

Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES.

Clin Immunol. 2008 Oct;129(1):163-9. Epub 2008 Aug 16.PMID: 18708298

 

2. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene

deletions contribute to APS I.

Bøe Wolff AS, Oftedal B, Johansson S, Bruland O, Løvås K, Meager A, Pedersen C, Husebye ES,

Knappskog PM.

Genes Immun. 2008 Mar;9(2):130-6. Epub 2008 Jan 17.PMID: 18200029

 

2026-2029           "AIRE, IL-12 and interferon-g; Drivers of immune tolerance and T cell function". Funded by the Norwegian research council. 12 000 000 NOK, Oftedal is the project leader.

2022-2027           “21-Hydroxylase reactive B cells and their immunotherapeutic potential in autoimmune Addison’s disease”. Funded by the Novo Nordic Fundation. 10 000 000 DKK. Oftedal is the project leader.

2021-2024           “Will B-cell tell the tales? Autoimmune B cells in autoimmune Addison’s disease”. Funded by the Regional Health Authorities. 3 000 000 NOK, Oftedal is the project leader.

2017-2021          “KG Jebsen center for autoimmune disorders”. A national centre established in Bergen, where Oftedal is a principal investigator. Funded by KG Jebsen, 18 000 000.

2017-2020          “Identification of novel monogenic autoimmune syndromes”. Partners are Husebye, Bratland and Wolff. Funded by Norwegian Research Council, 4 000 000 NOK.

2016-2019          “New perspectives on regulation of peripheral tissue antigen expression within the thymus”. Oftedal is the project leader. Partners are Georg Holländer and Eystein Husebye. Funded by the Norwegian Research Council. 3 328 000 NOK

 

Normal 0 false false false EN-GB X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;}